Latanoprost is an antiglaucoma drug, an analog of prostaglandin F2α and a selective FP receptor agonist. It reduces intraocular pressure by increasing the outflow of aqueous humor, mainly along the uveoscleral pathway. Latanoprost does not have a significant effect on the production of aqueous humor and does not affect the blood-ophthalmic barrier. A decrease in […]
read more...